News

Dr. Marty Makary, chief of the FDA, has expressed doubts about the agency approving the COVID-19 vaccine for winter, stating ...
Kennedy won Senate confirmation to his job, in part, by promising not to change the nation’s vaccine schedule. Since taking ...
The US Food and Drug Administration will require all new vaccines to undergo placebo-controlled trials before approval — a ...
Former government health officials fear the Trump administration is moving to slow-walk vaccine approvals, including by ...
The US Food and Drug Administration has discussed with vaccine-maker Novavax the need for an additional trial of its Covid-19 ...
The U.S. FDA is planning to require all new vaccines to undergo placebo-controlled trials before approval. Read more here.
“Under Secretary Kennedy’s leadership, all new vaccines will undergo safety testing in placebo-controlled trials prior to ...
Mr. Kennedy’s activism in recent years included petitioning the Food and Drug Administration to pull the Covid vaccine off the market in 2021, during a deadly phase of the pandemic.
The FDA is expected to unpause the only protein-based COVID-19 vaccine's transition from emergency approval to full approval.
Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — When Marty ...
Novavax said Monday that the Food and Drug Administration was asking the company to run a new clinical trial of its vaccine after the agency grants full approval. The company said it had responded ...